ArticleBMC endocrine disorders2019

All-cause mortality of insulin plus dipeptidyl peptidase-4 inhibitors in persons with type 2 diabetes.

Fu-Shun Yen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.